Compared with the insulin and lipid profiles in the mice fed high-fat diet (HFD), the administration of LPS via subcutaneous infusions into mice could cause the same outcome: increased insulin resistance and obesity [94]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.